New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 8, 2013
07:59 EDTCLDXCelldex reiterated as a Focus Pick at Roth Capital
Roth Capital reiterated Celldex as its Focus Pick citing its broad pipeline and the potential for accelerated approval for either ORR or PFS. Shares are Buy rated with a $16 price target.
News For CLDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
16:03 EDTCLDXCelldex completes enrollment in Phase 3 ACT IV study
Subscribe for More Information
December 5, 2014
08:44 EDTCLDXCelldex study should increase visibility, partner potential, says Roth Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use